Shares of Cell Therapeutics Inc. (Nasdaq: CTIC) continued climbing by rising 33 cents to $1.48 after the biopharmaceutical reported sharply narrower first quarter losses last week.
Cell Therapeutics Narrows Losses
May 11, 2009 at 13:59 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.